Literature DB >> 23397279

Decreasing the diabetic complication by vanadyl(VO)2+/vitamin B 6 complex in alloxan-induced diabetic mice.

Nahla S El-Shenawy1, Moamen S Refat, Fatima H Fakihi.   

Abstract

The scope of this work was to synthesize a novel bifunctionalized vanadyl(VO)(2+)/vitamin B 6 complex. The diabetic therapeutic efficacy of the new complex was investigated in alloxan-induced diabetic mice. The results suggested that vanadyl(VO)(2+)/vit B6 complex has an anti-diabetic potency, improved the lipid profile and liver and kidney functions. The new complex possesses an antioxidant activity. The current results support the therapeutic potentiality of vanadyl(VO)(2+)/vitamin B 6 complex for the management of diabetes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397279     DOI: 10.1007/s10856-013-4852-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  60 in total

1.  ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice.

Authors:  Leda M Oliveri; Carlos Davio; Alcira M del C Batlle; Esther N Gerez
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

3.  Evaluation of Oxidative Stress in Type 2 Diabetes Mellitus and Follow-up Along with Vitamin E Supplementation.

Authors:  Sarita N Shinde; Vithal N Dhadke; Adinath N Suryakar
Journal:  Indian J Clin Biochem       Date:  2010-12-22

Review 4.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

Review 5.  Vanadium--an element of atypical biological significance.

Authors:  Biswajit Mukherjee; Balaram Patra; Sushmita Mahapatra; Pratik Banerjee; Amit Tiwari; Malay Chatterjee
Journal:  Toxicol Lett       Date:  2004-04-21       Impact factor: 4.372

6.  Synthesis and characterization of norfloxacin-transition metal complexes (group 11, IB): spectroscopic, thermal, kinetic measurements and biological activity.

Authors:  Moamen S Refat
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2007-03-03       Impact factor: 4.098

7.  Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.

Authors:  Yanfen Niu; Weiping Liu; Changfu Tian; Mingjin Xie; Lihui Gao; Zhihe Chen; Xizhu Chen; Ling Li
Journal:  Eur J Pharmacol       Date:  2007-06-19       Impact factor: 4.432

8.  Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats.

Authors:  Kasi Ravi; Balasubramanian Ramachandran; Sorimuthu Subramanian
Journal:  Biol Pharm Bull       Date:  2004-08       Impact factor: 2.233

9.  Antioxidants and lipid peroxidation status in diabetic patients with and without complications.

Authors:  Rama Srivatsan; Sujata Das; Ranjita Gadde; Krishna Manoj-Kumar; Snigdha Taduri; Nageshwara Rao; B Ramesh; Akanksha Baharani; Kaajal Shah; Srilakshmi C Kamireddy; G Priyatham; T A Balakumaran; Shubha Seshadri Balakumaran; Asha Kamath; Anjali Rao
Journal:  Arch Iran Med       Date:  2009-03       Impact factor: 1.354

10.  Antidiabetic activity of Boerhaavia diffusa L.: effect on hepatic key enzymes in experimental diabetes.

Authors:  L Pari; M Amarnath Satheesh
Journal:  J Ethnopharmacol       Date:  2004-03       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.